|
February 21, 2018 Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com 1:23 Mylan Receives Tentative Approval for Combination HIV Treatment Dolutegravir, Emtricitabine, and Tenofovir Alafenamide Tablets Under FDA's PEPFAR Program - Feb 20, 2018 http://newsroom.mylan.com/2018-02-20-Mylan-Receives-Tentative-Approval-for-Combination-HIV-Treatment-DTG-FTC-TAF-Under-FDAs-PEPFAR-Program https://www.prnewswire.com/news-releases/mylan-receives-tentative-approval-for-combination-hiv-treatment-dtgftctaf-under-fdas-pepfar-program-300600851.html 3:20 FDA approves expanded indication of UroLift® System for BPH http://www.mdmag.com/medical-news/fda-approves-expanded-indication-for-bph-treatment https://www.businesswire.com/news/home/20180220005088/en/NeoTract-Announces-FDA-Clearance-Expanded-Indications-UroLift%C2%AE 5:20 Intralytix Receives FDA Clearance to Initiate Phase I/IIa clinical trials of bacteriophages specifically designed to treat inflammatory bowel diseases https://www.prnewswire.com/news-releases/intralytix-receives-fda-clearance-to-initiate-phase-i--iia-clinical-trials-300599772.html Please go to aimedicinenews.com for Emma Nichols' weekly podcast about AI in medicine. Austin Caudle, Associate Director, R&D Solutions at IQVIA, describes how the company uses data to help clients develop clinical trial protocols and identify hard-to-find patients for clinical trials. “A lot of people don’t really realize the scale and complexity of working with data,” he says. “We spent the last 4 years an advanced healthcare data cloud resulting in 300 technology patents and patent applications.” Find out more. Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/ |